• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于急性和慢性心力衰竭的生物传感器的方法和挑战。

Approaches and Challenges for Biosensors for Acute and Chronic Heart Failure.

机构信息

Department of Analytical Chemistry, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara 06018, Turkey.

Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara 06560, Turkey.

出版信息

Biosensors (Basel). 2023 Feb 16;13(2):282. doi: 10.3390/bios13020282.

DOI:10.3390/bios13020282
PMID:36832048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9954479/
Abstract

Heart failure (HF) is a cardiovascular disease defined by several symptoms that occur when the heart cannot supply the blood needed by the tissues. HF, which affects approximately 64 million people worldwide and whose incidence and prevalence are increasing, has an important place in terms of public health and healthcare costs. Therefore, developing and enhancing diagnostic and prognostic sensors is an urgent need. Using various biomarkers for this purpose is a significant breakthrough. It is possible to classify the biomarkers used in HF: associated with myocardial and vascular stretch (B-type natriuretic peptide (BNP), N-terminal proBNP and troponin), related to neurohormonal pathways (aldosterone and plasma renin activity), and associated with myocardial fibrosis and hypertrophy (soluble suppression of tumorigenicity 2 and galactin 3). There is an increasing demand for the design of fast, portable, and low-cost biosensing devices for the biomarkers related to HF. Biosensors play a significant role in early diagnosis as an alternative to time-consuming and expensive laboratory analysis. In this review, the most influential and novel biosensor applications for acute and chronic HF will be discussed in detail. These studies will be evaluated in terms of advantages, disadvantages, sensitivity, applicability, user-friendliness, etc.

摘要

心力衰竭(HF)是一种心血管疾病,其特征是当心脏无法向组织供应所需的血液时出现多种症状。HF 影响着全球约 6400 万人,其发病率和患病率正在上升,因此在公共卫生和医疗保健成本方面占有重要地位。因此,开发和增强诊断和预后传感器是当务之急。为此目的使用各种生物标志物是一个重大突破。可以对用于 HF 的生物标志物进行分类:与心肌和血管拉伸相关的(B 型利钠肽(BNP)、N 末端 proBNP 和肌钙蛋白)、与神经激素途径相关的(醛固酮和血浆肾素活性)以及与心肌纤维化和肥大相关的(可溶性肿瘤抑制因子 2 和半乳糖凝集素 3)。对于与 HF 相关的生物标志物,人们对设计快速、便携式和低成本生物传感设备的需求越来越大。生物传感器在早期诊断中作为耗时且昂贵的实验室分析的替代方法发挥着重要作用。在这篇综述中,将详细讨论用于急性和慢性 HF 的最具影响力和新颖的生物传感器应用。将根据优点、缺点、灵敏度、适用性、用户友好性等方面对这些研究进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/8ec6fda082ef/biosensors-13-00282-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/18e22b2a3991/biosensors-13-00282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/e549bf78d47e/biosensors-13-00282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/e5a96d2b6695/biosensors-13-00282-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/d2416e5d3e10/biosensors-13-00282-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/15134d3422cf/biosensors-13-00282-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/7b9ac53b4732/biosensors-13-00282-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/8ec6fda082ef/biosensors-13-00282-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/18e22b2a3991/biosensors-13-00282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/e549bf78d47e/biosensors-13-00282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/e5a96d2b6695/biosensors-13-00282-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/d2416e5d3e10/biosensors-13-00282-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/15134d3422cf/biosensors-13-00282-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/7b9ac53b4732/biosensors-13-00282-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/796e/9954479/8ec6fda082ef/biosensors-13-00282-g007.jpg

相似文献

1
Approaches and Challenges for Biosensors for Acute and Chronic Heart Failure.用于急性和慢性心力衰竭的生物传感器的方法和挑战。
Biosensors (Basel). 2023 Feb 16;13(2):282. doi: 10.3390/bios13020282.
2
Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors.迈向即时心力衰竭诊断平台:BNP 和 NT-proBNP 生物传感器。
Sensors (Basel). 2019 Nov 16;19(22):5003. doi: 10.3390/s19225003.
3
The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.心血管危险因素稳定门诊患者中N末端B型利钠肽原/ B型利钠肽的摩尔比与心力衰竭相关事件的关系
Intern Med. 2018 Sep 15;57(18):2621-2630. doi: 10.2169/internalmedicine.0471-17. Epub 2018 Apr 27.
4
Electrochemical cardiovascular platforms: Current state of the art and beyond.电化学心血管平台:现状与展望。
Biosens Bioelectron. 2019 Apr 15;131:287-298. doi: 10.1016/j.bios.2019.02.010. Epub 2019 Feb 19.
5
Biomarkers and diagnostics in heart failure.心力衰竭中的生物标志物与诊断方法
Biochim Biophys Acta. 2013 Dec;1832(12):2442-50. doi: 10.1016/j.bbadis.2012.12.014. Epub 2013 Jan 9.
6
Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.心力衰竭预后评估的多标志物策略。神经激素生物标志物的价值:中性肽链内切酶与N末端脑钠肽前体
Rev Esp Cardiol (Engl Ed). 2015 Dec;68(12):1075-84. doi: 10.1016/j.rec.2015.07.001. Epub 2015 Aug 19.
7
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.sST2 预测慢性心力衰竭的结局优于 NT-proBNP 和高敏肌钙蛋白 T。
J Am Coll Cardiol. 2018 Nov 6;72(19):2309-2320. doi: 10.1016/j.jacc.2018.08.2165.
8
The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.利钠肽及其他生物标志物在心力衰竭诊断、预后及管理中的潜在作用。
Expert Rev Cardiovasc Ther. 2015;13(9):1017-30. doi: 10.1586/14779072.2015.1071664. Epub 2015 Jul 21.
9
Biosensors for natriuretic peptides in cardiovascular diseases. A review.心血管疾病中利钠肽的生物传感器。综述。
Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102180. doi: 10.1016/j.cpcardiol.2023.102180. Epub 2023 Oct 29.
10
Advances in heart failure monitoring: Biosensors targeting molecular markers in peripheral bio-fluids.心力衰竭监测的新进展:外周生物流体中分子标志物的生物传感器。
Biosens Bioelectron. 2024 Jul 1;255:116090. doi: 10.1016/j.bios.2024.116090. Epub 2024 Feb 5.

引用本文的文献

1
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling.心肌细胞与基质细胞的相互作用影响致心律失常性心肌病的发病机制:多层次分析揭示DLK1-NOTCH通路在纤维脂肪重塑中的作用。
Cell Death Discov. 2024 Nov 28;10(1):484. doi: 10.1038/s41420-024-02232-8.
2
Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review.评估生物标志物作为心力衰竭早期检测和预后工具的研究:一项综述
Card Fail Rev. 2024 Jun 3;10:e06. doi: 10.15420/cfr.2023.24. eCollection 2024.
3

本文引用的文献

1
Paper disc interfaced Prussian blue nanocube modified immunodevice for electrochemical detection of diverse biomarker at point of care.用于即时检测多种生物标志物的纸盘界面普鲁士蓝纳米立方体修饰免疫装置
Bioelectrochemistry. 2023 Apr;150:108346. doi: 10.1016/j.bioelechem.2022.108346. Epub 2022 Dec 5.
2
Sensitive electrochemical detection of polymorphisms in IL6 and TGFβ1 genes from ovarian cancer DNA patients using EcoRI and DNA hairpin-modified gold electrodes.利用 EcoRI 和 DNA 发夹修饰的金电极,对卵巢癌 DNA 患者的 IL6 和 TGFβ1 基因多态性进行灵敏电化学检测。
Mikrochim Acta. 2022 Dec 7;190(1):15. doi: 10.1007/s00604-022-05595-w.
3
Improving the Prognostic Evaluation Precision of Hospital Outcomes for Heart Failure Using Admission Notes and Clinical Tabular Data: Multimodal Deep Learning Model.
利用入院记录和临床表格数据提高心力衰竭住院结局预后评估的精准度:多模态深度学习模型。
J Med Internet Res. 2024 May 2;26:e54363. doi: 10.2196/54363.
4
An impedimetric immunosensor based on chitosan-Au nanoparticles-reduced graphene oxide nanosheet composite modified PG electrode for detection of brain natriuretic peptide.一种基于壳聚糖-金纳米粒子-还原氧化石墨烯纳米片复合材料修饰玻碳电极的阻抗免疫传感器,用于检测脑钠肽。
3 Biotech. 2023 Aug;13(8):280. doi: 10.1007/s13205-023-03704-x. Epub 2023 Jul 24.
5
Molecularly Imprinted Polymer-Based Sensors for the Detection of Skeletal- and Cardiac-Muscle-Related Analytes.基于分子印迹聚合物的用于检测骨骼和心脏肌肉相关分析物的传感器。
Sensors (Basel). 2023 Jun 15;23(12):5625. doi: 10.3390/s23125625.
New Biomarkers and Their Potential Role in Heart Failure Treatment Optimisation-An African Perspective.
新型生物标志物及其在优化心力衰竭治疗中的潜在作用——非洲视角
J Cardiovasc Dev Dis. 2022 Oct 2;9(10):335. doi: 10.3390/jcdd9100335.
4
Electrochemical sensor based on micromotor technology for detection of Ox-LDL in whole blood.基于微电机技术的电化学传感器用于检测全血中的 Ox-LDL。
Biosens Bioelectron. 2022 Dec 1;217:114682. doi: 10.1016/j.bios.2022.114682. Epub 2022 Sep 5.
5
Highly sensitive sandwich-type immunosensor with enhanced electrocatalytic durian-shaped MoS/AuPtPd nanoparticles for human growth differentiation factor-15 detection.高灵敏三明治型免疫传感器,具有增强电催化作用的榴莲状 MoS/AuPtPd 纳米粒子,用于检测人生长分化因子-15。
Anal Chim Acta. 2022 Aug 29;1223:340194. doi: 10.1016/j.aca.2022.340194. Epub 2022 Jul 31.
6
A novel electrochemical strategy for NT-proBNP detection using IMFET for monitoring heart failure by saliva analysis.一种使用离子敏场效应晶体管(IMFET)通过唾液分析监测心力衰竭来检测N末端B型利钠肽原(NT-proBNP)的新型电化学策略。
Talanta. 2023 Jan 1;251:123759. doi: 10.1016/j.talanta.2022.123759. Epub 2022 Aug 5.
7
A sensitive ratiometric biosensor for determination cardiac troponin I of myocardial infarction markers based on N, Zn-GQDs.基于 N、Zn-GQDs 的心肌梗死标志物肌钙蛋白 I 灵敏比率型生物传感器的研究
Talanta. 2022 Nov 1;249:123577. doi: 10.1016/j.talanta.2022.123577. Epub 2022 May 20.
8
Biomarkers in heart failure: Relevance in the clinical practice.心力衰竭的生物标志物:临床实践中的相关性。
Int J Cardiol. 2022 Sep 15;363:196-201. doi: 10.1016/j.ijcard.2022.06.039. Epub 2022 Jun 15.
9
Aptamers Targeting Cardiac Biomarkers as an Analytical Tool for the Diagnostics of Cardiovascular Diseases: A Review.靶向心脏生物标志物的适体作为心血管疾病诊断的分析工具:综述
Biomedicines. 2022 May 6;10(5):1085. doi: 10.3390/biomedicines10051085.
10
Detection Efficiency of Ag Nanoparticle Labels for a Heart Failure Marker Using Linear and Square-Wave Anodic Stripping Voltammetry.基于线性和方波溶出伏安法的纳米银标记物检测心力衰竭标志物的效率。
Biosensors (Basel). 2022 Mar 29;12(4):203. doi: 10.3390/bios12040203.